The Lymphoma Academic Research Organisation
Clinical trials sponsored by The Lymphoma Academic Research Organisation, explained in plain language.
-
New drug combo trial aims to wipe out hidden cancer cells
Disease control OngoingThis trial is testing two different drug combinations for people newly diagnosed with mantle cell lymphoma, a type of blood cancer. It will compare a two-drug regimen (ibrutinib plus an antibody) against a three-drug regimen that adds a medication called venetoclax. The main goal…
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope pill tested for lymphoma that Won't quit
Disease control OngoingThis study is testing an experimental daily pill called valemetostat for adults whose B-cell lymphoma has returned or hasn't responded to standard treatments. The main goal is to see how well the drug shrinks tumors and how safe it is for patients who have few other options. Abou…
Phase: PHASE2 • Sponsor: The Lymphoma Academic Research Organisation • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC